Drug Enforcement D-002-2014

Resuspension Problems: Recalled lot did not meet resuspendability requirements.

Status

Terminated

Classification

Class II

Report Date

November 27, 2013

Termination Date

February 11, 2014

Product Information

Product description
Oxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories, Inc. Columbus, Ohio 43216, NDC 0054-0199-59
Product quantity
10,267 bottles
Reason for recall
Resuspension Problems: Recalled lot did not meet resuspendability requirements.
Recall initiation reason
Initial firm notification
Letter
Distribution pattern
Nationwide

Location & Firm

Recalling firm
Boehringer Ingelheim Roxane Inc
Address
1809 Wilson Rd

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date

Codes & Dates

Recall number
D-002-2014
Event ID
66289
Recall initiation date
April 3, 2013
Center classification date
November 20, 2013
Code info
Lot # 161304B, Exp. OCT 2013
More code info